Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled study.
about
Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agentsRetinoid roles in blocking hepatocellular carcinomaSupportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver functionSurgical outcomes of hepatocellular carcinoma with biliary tumor thrombus: a systematic reviewA genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deteriorationChemopreventive potential of green tea catechins in hepatocellular carcinoma.Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.Survey of survival among patients with hepatitis C virus-related hepatocellular carcinoma treated with peretinoin, an acyclic retinoid, after the completion of a randomized, placebo-controlled trial.Hepatitis C virus-induced hepatocellular carcinomaRetinoids and rexinoids in cancer prevention: from laboratory to clinic.Peretinoin as an adjuvant therapy for hepatocellular carcinoma.Acyclic retinoid induces differentiation and apoptosis of murine hepatic stem cells.Hepatic stellate cells as key target in liver fibrosis.MHC class I-related chain B gene polymorphism is associated with virological response to pegylated interferon plus ribavirin therapy in patients with chronic hepatitis C infection.Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.Molecular Targeted Therapy for Hepatocellular Carcinoma: Where Are We Now?Molecular Targeted Agents for Hepatocellular Carcinoma: Current Status and Future Perspectives.Peretinoin, an acyclic retinoid, inhibits hepatocarcinogenesis by suppressing sphingosine kinase 1 expression in vitro and in vivo.Prevention of hepatocellular carcinoma by targeting MYCN-positive liver cancer stem cells with acyclic retinoid.AASLD guidelines for the treatment of hepatocellular carcinoma
P2860
Q26772302-C3A2193E-4290-4B73-94EB-C949A34C5A31Q26796665-D3282DB4-DE34-4666-8F45-B06A1B97F657Q28066295-4FF66506-5752-45AE-8743-CD19423B70BCQ28079752-9E0C910A-DAB7-419C-A671-0849B3D379A6Q35107005-3F4E6DC0-7944-4357-BC4C-1D9126F95D25Q35381561-7D576C64-0BA8-46CB-8025-AAF90527B5E8Q35619104-65B79207-E949-4C45-BBA7-0FF9747D76A9Q35698198-F152F81F-60C5-4D1C-BFC7-9A4A12DEDAD3Q35824057-1BE11CCF-6D2D-42CD-86F6-3B1F71FC1E2AQ36680198-8C175B25-602B-4426-BC37-6D94601C0991Q38959682-96B54538-543C-4E43-BD43-5E231BF4BDCBQ40180802-13F2605E-E9FF-4F67-AC3E-3F94E78305A4Q40200602-B11F7CF8-9869-4E97-B1C7-C385032C32C5Q41161023-8527414D-BDAF-4195-9906-C39572336947Q41921861-B62833FB-57F1-49CD-BA78-76942D548842Q41962614-DCF61F1A-BE60-4AC7-A376-E8A4B69BAD00Q42169289-565EFF07-C329-4C60-ABE0-4D6C5531BC09Q42317924-A9A332E7-5301-401D-A48A-9D383A8EC49FQ47167981-C04C501D-2027-4DA4-A199-F0F7974D5822Q52568671-24924ED2-9D3A-4F93-991E-983D551A9159Q56172239-97217603-F71E-4605-B872-674EAC04F95F
P2860
Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled study.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Peretinoin after curative ther ...... lind placebo-controlled study.
@ast
Peretinoin after curative ther ...... lind placebo-controlled study.
@en
type
label
Peretinoin after curative ther ...... lind placebo-controlled study.
@ast
Peretinoin after curative ther ...... lind placebo-controlled study.
@en
prefLabel
Peretinoin after curative ther ...... lind placebo-controlled study.
@ast
Peretinoin after curative ther ...... lind placebo-controlled study.
@en
P2093
P2860
P50
P1476
Peretinoin after curative ther ...... lind placebo-controlled study.
@en
P2093
Hiromitsu Kumada
Hisataka Moriwaki
Katsuaki Tanaka
Kazuho Imanaka
Kazushi Numata
Kenichi Ido
Kenji Ikeda
Kiwamu Okita
Kohei Nakachi
Namiki Izumi
P2860
P304
P356
10.1007/S00535-014-0956-9
P577
2014-04-13T00:00:00Z